• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,108
3,508
3,391
2,812
2,749

COUNTRY

2,358
866
275
262
226

CATEGORIES

  • 929
  • 173
  • 114
  • 290
    • 49
  • 498
  • 259
  • 237
  • 56
  • 62
  • 839
  • 1,484
  • 821
  • 18
  • 487
  • 1,411
  • 2,352
    • 85
    • 124
    • 66
    • 65
    • 37
    • 36
    • 12
    • 12
    • 12
    • 18
  • 23
  • 267
  • 35
  • 2,588
SHOW ALL…

PRICE

2,323
7,668
16,062
28,461

PUBLISHED

2,261
6,774
12,208
28,461

PRODUCT TYPE

25,999
1,058
1,025
163
81
61
21
21
16
9
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014

Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Cardiomyopathy...

September 2014
FROM

Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014

Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014" provides data on...

September 2014
FROM

Pericarditis Global Clinical Trials Review, H2, 2014

Pericarditis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Pericarditis Global Clinical Trials Review, H2, 2014" provides data on the Pericarditis clinical trial scenario....

September 2014
FROM

Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014

Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014" provides data on the Ischemia...

September 2014
FROM

Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014

Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014" provides data...

September 2014
FROM

Myocardial Ischemia Global Clinical Trials Review, H2, 2014

Myocardial Ischemia Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Myocardial Ischemia...

September 2014
FROM

Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014

Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data...

September 2014
FROM

The Asia Pacific Markets For PCR Technologies

During the past three decades since its invention, PCR has evolved to become one of the fundamental technology platforms in life sciences sector. The application segments of this platform are still...

September 2014
FROM

Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014

Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014" provides...

September 2014
FROM

Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014

Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Hypertropic...

September 2014
FROM

Hyperemia Global Clinical Trials Review, H2, 2014

Hyperemia Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Hyperemia Global Clinical Trials Review, H2, 2014" provides data on the Hyperemia clinical trial scenario. This...

September 2014
FROM

Intermittent Claudication Global Clinical Trials Review, H2, 2014

Intermittent Claudication Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Intermittent Claudication Global Clinical Trials Review, H2, 2014" provides data on the Intermittent...

September 2014
FROM

Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014

Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014" provides data...

September 2014
FROM
Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins - Product Thumbnail Image

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competitor evaluation in the field of marketed and new molecules for prevention or treatment...

September 2014
FROM
Depilatories in Portugal Depilatories in Portugal - Product Thumbnail Image

Depilatories in Portugal

The trend towards personal appearance, coupled with Portugal’s seaside location and declining disposable incomes, continued to benefit depilatories in 2013; primarily hair removers/bleaches and women’s...

September 2014
FROM

Lyophilization Market by Equipment Type, Industry, Technology & Geography - Global Trends & Forecast to 2019

Lyophilization Market by Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, Surgical Procedure, & Others), Technology (Tray-style, Manifold,...

September 2014
FROM
Depilatories in the United Arab Emirates Depilatories in the United Arab Emirates - Product Thumbnail Image

Depilatories in the United Arab Emirates

Hair removal is a key grooming priority for the majority of Arab and Western women living in the United Arab Emirates. Western women are generally accustomed to using these products in their home countries...

September 2014
FROM

OTC Pharmaceuticals in Saudi Arabia

Introduction OTC Pharmaceuticals in Saudi Arabia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The...

September 2014
FROM

OTC Pharmaceuticals in Belgium

Introduction OTC Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The profile...

September 2014
FROM

OTC Pharmaceuticals in China

Introduction OTC Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The profile...

September 2014
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S